|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.02 EUR | +3.22% |
|
+5.30% | -0.71% |
| Jan. 28 | Medincell S.A. Provides Revenue Guidance for the Year 2026 | CI |
| Jan. 28 | MedinCell says Uzedy net sales increased 63% to $191 million in 2025 | RE |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | - | 8 | ||||||
| - | 27 | ||||||
| - | 24 | ||||||
| - | 27 | ||||||
| - | 20 | ||||||
| - | 21 | ||||||
| - | 21 | ||||||
| - | 26 | ||||||
| - | 22 | ||||||
| - | 27 | ||||||
| - | 26 | ||||||
| - | 24 | ||||||
| - | 23 | ||||||
| - | 26 | ||||||
| - | 20 | ||||||
| - | 23 | ||||||
| - | 15 | ||||||
| - | 15 | ||||||
| - | 17 | ||||||
| - | 20 | ||||||
| Average | 22 | |||||||
| Weighted average by Cap. | 24 |
- Stock Market
- Equities
- MEDCL Stock
- Sector MedinCell S.A.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
